NCPC: In the third quarter, the net profit attributable to the parent company was 35.0066 million yuan, an increase of 14.85% year-on-yearZhitong·Oct 24, 2025 at 07:26 AM600812-0.21%
NCPC: Wholly-owned subsidiary receives approval notice for the listing application of Cefoperazone chemical raw materialsZhitong·Oct 9, 2025 at 04:20 AM600812-0.21%
NCPC: Southern Company Obtains Drug Registration CertificateZhitong·Sep 16, 2025 at 04:13 AM600812-0.21%
NCPC has obtained the drug registration certificate for injectable vancomycin hydrochloride (0.5g)Zhitong·Sep 2, 2025 at 05:19 AM600812-0.21%
NCPC released its semi-annual performance report, with a net profit attributable to the parent company of 123 million yuan, a year-on-year increase of 71.56%Zhitong·Aug 13, 2025 at 06:42 AM600812-0.21%
NCPC: Adenosylcobalamin Capsules (0.5mg) have obtained the drug registration certificateZhitong·Jul 29, 2025 at 03:58 AM600812-0.21%
NCPC's subsidiary has obtained the CEP certificate for Sulfomycetin B active pharmaceutical ingredientZhitong·Jul 15, 2025 at 03:59 AM600812-0.21%
NCPC issued a preliminary increase, expecting a net profit attributable to the parent company of approximately 123.5 million yuan in the first half of the year, an increase of 72% year-on-yearZhitong·Jul 10, 2025 at 04:03 AM600812-0.21%
NCPC's subsidiary has received the approval notice for the marketing application of Sulfate Polymyxin B chemical raw materialsZhitong·Jun 10, 2025 at 04:53 AM600812-0.21%
NCPC's subsidiary has obtained the drug registration certificate for injectable Ceftazidime Avibactam SodiumZhitong·Jun 10, 2025 at 04:51 AM600812-0.21%
NCPC has obtained the drug registration certificate for injectable isavuconazoleZhitong·Jun 5, 2025 at 04:50 AM600812-0.21%
NCPC: Restructured Tetanus Vaccine (Escherichia coli) Clinical Trial ApprovedZhitong·May 15, 2025 at 03:28 AM600812-0.21%
NCPC released its first-quarter performance, with a net profit attributable to the parent company of 57.4916 million yuan, a year-on-year increase of 216.72%Zhitong·Apr 23, 2025 at 06:21 AM600812-0.21%
NCPC: Has begun the deployment of the DeepSeek large modelZhitong·Apr 16, 2025 at 03:51 AM600812-0.21%
NCPC released its 2024 annual performance, with a net profit attributable to the parent company of 127 million yuan, a year-on-year increase of 2496.8%Zhitong·Mar 27, 2025 at 09:49 AM600812-0.21%
